|
Q4 2024
|
289 |
3,607,987 |
BSX, LLY, IT, AMZN
|
13F-HR
|
2/14/2025 |
000092963825000729 |
|
Q3 2024
|
305 |
3,758,562 |
BSX, LLY, IT, AMZN
|
13F-HR
|
11/13/2024 |
000092963824003845 |
|
Q2 2024
|
304 |
3,544,218 |
BSX, LLY, IT, AMZN
|
13F-HR
|
8/14/2024 |
000092963824002788 |
|
Q1 2024
|
305 |
3,306,029 |
BSX, LLY, IT, AMZN
|
13F-HR
|
5/13/2024 |
000092963824001771 |
|
Q4 2023
|
311 |
2,875,682 |
BSX, IT, LLY, AMZN
|
13F-HR
|
2/13/2024 |
000092963824000547 |
|
Q3 2023
|
378 |
2,717,201 |
BSX, LLY, IT, AMZN
|
13F-HR
|
11/14/2023 |
000092963823003095 |
|
Q2 2023
|
684 |
2,939,705 |
BSX, IT, LLY, AMZN
|
13F-HR
|
8/14/2023 |
000092963823002241 |
|
Q1 2023
|
292 |
2,768,266 |
BSX, IT, LLY, AMZN
|
13F-HR
|
5/12/2023 |
000092963823001421 |
|
Q4 2022
|
288 |
2,617,763 |
BSX, IT, LLY, NEE
|
13F-HR
|
2/10/2023 |
000092963823000348 |
|
Q3 2022
|
295 |
2,379,967 |
BSX, IT, AMZN, LLY
|
13F-HR
|
11/9/2022 |
000156761922019390 |
|
Q2 2022
|
298 |
2,467,670 |
BSX, IT, AMZN, LLY
|
13F-HR
|
8/12/2022 |
000156761922015663 |
|
Q1 2022
|
436 |
3,125,957 |
BSX, AMZN, IT, MSFT
|
13F-HR
|
5/12/2022 |
000156761922010257 |
|
Q4 2021
|
441 |
3,123,910 |
BSX, AMZN, IT, MSFT
|
13F-HR
|
2/11/2022 |
000156761922003436 |
|
Q3 2021
|
430 |
3,052,983 |
BSX, AMZN, IT, MSFT
|
13F-HR
|
11/12/2021 |
000156761921019802 |
|
Q2 2021
|
427 |
3,153,681 |
BSX, AMZN, PYPL, IT
|
13F-HR
|
8/12/2021 |
000156761921015247 |
|
Q1 2021
|
438 |
2,854,420 |
BSX, AMZN, PYPL, MSFT
|
13F-HR
|
5/11/2021 |
000156761921009535 |
|
Q4 2020
|
442 |
2,685,507 |
BSX, AMZN, PYPL, BABA
|
13F-HR
|
2/4/2021 |
000156761921002169 |
|
Q3 2020
|
446 |
2,775,078 |
BSX, AMZN, BABA, PYPL
|
13F-HR
|
11/12/2020 |
000156761920019193 |
|
Q2 2020
|
463 |
2,545,422 |
BSX, AMZN, BABA, MSFT
|
13F-HR
|
8/13/2020 |
000156761920015029 |
|
Q1 2020
|
238 |
2,250,086 |
BSX, AMZN, BABA, NEE
|
13F-HR
|
5/14/2020 |
000156761920010083 |
|
Q4 2019
|
236 |
3,080,463 |
BSX, AMZN, BABA, BA
|
13F-HR
|
2/10/2020 |
000156761920002565 |
|
Q3 2019
|
239 |
2,847,561 |
BSX, AMZN, BA, IT
|
13F-HR
|
11/13/2019 |
000156761919021099 |
|
Q2 2019
|
254 |
2,902,300 |
BSX, AMZN, BA, IT
|
13F-HR
|
8/13/2019 |
000156761919016481 |
|
Q1 2019
|
266 |
2,649,176 |
BSX, AMZN, BA, IT
|
13F-HR
|
5/10/2019 |
000156761919010428 |
|
Q4 2018
|
268 |
2,267,465 |
BSX, AMZN, CARG, BA
|
13F-HR
|
2/5/2019 |
000156761919002312 |
|
Q3 2018
|
274 |
2,487,399 |
BSX, CARG, AMZN, BA
|
13F-HR
|
11/8/2018 |
000156761918005326 |
|
Q2 2018
|
268 |
2,176,854 |
BSX, CARG, AMZN, BABA
|
13F-HR
|
8/9/2018 |
000156761918000233 |
|
Q1 2018
|
267 |
2,011,531 |
BSX, CARG, AMZN, BABA
|
13F-HR
|
5/14/2018 |
000114036118023148 |
|
Q4 2017
|
258 |
2,080,174 |
BSX, CARG, AMZN, BA
|
13F-HR
|
1/29/2018 |
000114036118003489 |
|
Q3 2017
|
269 |
1,896,755 |
BSX, BABA, EPD, BA
|
13F-HR
|
10/27/2017 |
000114036117039810 |
|
Q2 2017
|
273 |
1,851,559 |
BSX, EPD, MMP, AMZN
|
13F-HR
|
7/20/2017 |
000114036117028215 |
|
Q1 2017
|
274 |
1,743,934 |
BSX, EPD, MMP, LLY
|
13F-HR
|
4/19/2017 |
000114036117016194 |
|
Q4 2016
|
271 |
1,533,120 |
BSX, EPD, MMP, LLY
|
13F-HR
|
1/25/2017 |
000114036117002781 |
|
Q3 2016
|
261 |
1,563,273 |
BSX, EPD, MMP, LLY
|
13F-HR
|
10/26/2016 |
000114036116083601 |
|
Q2 2016
|
258 |
1,463,877 |
BSX, EPD, MMP, LLY
|
13F-HR
|
7/20/2016 |
000114036116072889 |
|
Q1 2016
|
261 |
1,241,759 |
BSX, Boston Scientific Corp Restric, EPD, MMP
|
13F-HR
|
5/9/2016 |
000114036116064069 |
|
Q4 2015
|
263 |
1,214,729 |
BSX, Boston Scientific Corp Restric, EPD, LLY
|
13F-HR
|
2/4/2016 |
000114036116050282 |
|
Q3 2015
|
276 |
1,219,286 |
BSX, Boston Scientific Corp Restric, EPD, LLY
|
13F-HR
|
10/30/2015 |
000114036115039130 |
|
Q2 2015
|
266 |
1,323,923 |
BSX, Boston Scientific Corp Restric, EPD, PAA
|
13F-HR
|
8/12/2015 |
000114036115031327 |
|
Q1 2015
|
270 |
1,343,004 |
BSX, Boston Scientific Corp Restric, EPD, PAA
|
13F-HR
|
5/12/2015 |
000114036115018990 |
|
Q4 2014
|
274 |
1,133,019 |
BSX, Boston Scientific Corp Restric, EPD, PAA
|
13F-HR
|
2/12/2015 |
000114036115005862 |
|
Q3 2014
|
287 |
1,058,927 |
BSX, Boston Scientific Corp Restric, EPD, PAA
|
13F-HR
|
11/14/2014 |
000114036114041931 |
|
Q2 2014
|
268 |
1,034,963 |
BSX, Boston Scientific Corp Restric, EPD, PAA
|
13F-HR
|
8/13/2014 |
000114036114032269 |
|
Q1 2014
|
265 |
988,824 |
BSX, Boston Scientific Corp Restric, EPD, PAA
|
13F-HR
|
5/14/2014 |
000114036114020748 |
|
Q4 2013
|
259 |
907,006 |
BSX, Boston Scientific Corp Restric, EPD, PAA
|
13F-HR
|
2/13/2014 |
000114036114006747 |